Molecular pathology of prostate cancer
"Inflammation has a role in many cancers. . . . Inflammatory cells produce numerous oxidants with potential to cause cellular or genomic damage in the prostate. There is accumulating knowledge supporting the role of inflammation in prostate cancer, including epidemiological studies showing that there is a decreased risk of prostate cancer associated with the intake of antioxidants or non-steroidal anti-inflammatory drugs."
"The evidence for a role of inflammation in prostate cancer is convincing with support from epidemiological, molecular, and histopathological studies. In the near future it may be common practice for the prescription of anti-inflammatory drugs to decrease the risk of development of prostate cancer, just as the prescription of aspirin is common practice now to decrease the risk of stroke."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment